Trial Profile
A Phase II Study of Concurrent Radiation and Temozolomide Followed By Temozolomide and CCNU in the Treatment of Children With High-Grade Glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Lomustine (Primary) ; Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2019 Status changed from active, no longer recruiting to completed.
- 24 Oct 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Nov 2010 Additional location (Puerto Rico) identified as reported by ClinicalTrials.gov.